Çà´ºÓÀפÊÇÈËÀà×·ÇóµÄ×îÖÕÃÎÏ룬¶øÐàÂõÈ´ÎÞ´¦²»ÔÚ¡¢²»¿É×èµ²¡¢²»¿ÉÄæת¡£
ÈËÀà¹ØÓÚÓÀÉúµÄÆÚÅÎ×Թžͱ£´æ£¬ÇØʼ»ÊÙøÕþÖ´×ÅÓÚ¶ÔÓÀÉú²»ÀÏÒ©µÄ×·Ñ°£¬¹Å°£¼°½ð×ÖËþµÄÐÞ½¨Ò²ÊÇÁíÒ»ÖÖÐÎʽ¶ÔÓÀÉúµÄÅÎÔ¸¡£ËäÈ»ÏÖÔÚÎÒÃÇ»¹ÎÞ·¨µÖ´ïÓÀÉú²»ÀϵÄˮƽ£¬µ«Ò²´Óδ×èÖ¹¶ÔÑÓ»ºÐàÂõµÄ̽Ë÷£¬Ëæ×Å¿ÆѧµÄÉú³¤»òÐíÄÜÈÃÑÓ»ºÐàÂõ³ÉΪ¿ÉÄÜ¡£Ììϸ÷¹úÑо¿ÕßÒ²ÖÂÁ¦ÓÚÐàÂõÉúÎïѧµÄÑо¿£¬Ö¼ÔÚ·¢Ã÷ÐàÂõµÄÇý¶¯ÒòËØ£¬É¸Ñ¡³öһЩDZÔڵġ°²»ÀÏÒ©¡±£¬´Ó¶øµÖ´ïÑÓ»ºÐàÂõ¡¢Ìá¸ßÉúÃüÖÊÁ¿µÄÄ¿µÄ¡£
×÷ΪһÖÖ°ë±ØÐèµÄ΢Á¿°±»ùËáµÄÅ£»ÇËá(Taurine)£¬ËüÓëÐàÂõÖ®¼äµÄ¹ØϵÔÚÏÈÇ°µÄÑо¿ÖÐÒ²ÏÔʾ³ö¼ÍÂÉ¡£ÓÐÑо¿Åúעţ»ÇËáÆä´úлÎïÔÚ»úÌåÄÚµÄŨ¶È»áËæ×ÅÄêËêµÄÔöÌí¶øϽµ£¬¶øÍâÔ´Ôö²¹Å£»ÇËá¶Ô´úлºÍÑ×Ö¢ÐÔ¼²²¡ÓÐÒæ[1,2]£¬¶ø»úÌåÅ£»ÇËáȱ·¦£¬Ò×ÒýÆð¹Ç÷À¼¡¡¢ÊÓÍøĤºÍÖÐÊàÉñ¾ÏµÍ³µÄ¹¦Ð§ÕÏ°¼°ÐàÂõÏà¹Ø¼²²¡µÄ±¬·¢[3,4]¡£»ùÓÚÉÏÊöÐàÂõÀú³ÌÖÐÅ£»ÇËáƷòµÄϽµ¼°ÆäÒÑÖªµÄ¿µ½¡Ó°ÏìµÄ·¢Ã÷£¬À´×ÔÓ¡¶È¹ú¼ÒÃâÒßѧÑо¿ËùµÄVijay K. YadavÍŶӿËÈÕÔÚScienceÔÓÖ¾ÉϽÒÏþÁËһƪÌâΪ¡°Taurine deficiency as a driver of aging¡±µÄÎÄÕ£¬Í¨¹ý²î±ðÎïÖÖÖÐÅ£»ÇËẬÁ¿×ª±äÀ´Ì½Ë÷Å£»ÇËáȱ·¦ÊÇ·ñÊÇÐàÂõµÄÇý¶¯ÒòËز¢Ó°Ï쿵½¡ÊÙÃü[5]¡£
ÏÂÃæÎÒÃÇÒ»ÆðÀ´¿´Ñо¿Ð§¹û~
01 Å£»ÇËáȱ·¦ÊÇÐàÂõµÄÇý¶¯ÒòËØ
ΪÁËÖÜÈ«Ñо¿Å£»ÇËáƷòÊÇ·ñÓ°Ï쿵½¡ÊÙÃü£¬Ñо¿Ö°Ô±²â¶¨ÁËСÊ󡢺ï×ÓºÍÈËÀà²î±ðÄêËêµÄѪÇåÅ£»ÇËáŨ¶È£¬·¢Ã÷ѪÇåÅ£»ÇËáŨ¶ÈÓëÄêËê³Ê¸ºÏà¹Ø£¨Í¼1. A-C£©¡£¶Ô14ÔÂÁäСÊóÔö²¹Å£»ÇËᣬÔò¿ÉÒÔÑÓÉìÕâЩСÊóµÄÊÙÃü£¨ÖÐλÊý10-12%£¬Í¼1. D, E£©¡£ÕâÖÖÅ£»ÇËáȱ·¦¿ÉÄÜÊÇÐàÂõÇý¶¯ÒòËصÄÕ÷Ï󣬲»µ«ÔÚ²¸È鶯ÎïÖлñµÃÑéÖ¤£¬ÔÚËæºóµÄÏß³æÑо¿ÖÐÒ²·ºÆðÁËÏàËƵÄЧ¹û£¨Í¼1. F£©¡£ÕâЩЧ¹ûÅú×¢£¬Å£»ÇËá¶ÔÊÙÃüµÄÓ°ÏìÔÚÎÞ¼¹×µ¶¯ÎïºÍ²¸È鶯ÎïÊÇÏàͬµÄ¡£
ͼ1 Å£»ÇËáȱ·¦ÊDzî±ðµÄÎïÖÖÐàÂõµÄÇý¶¯ÒòËØ
02 Ôö²¹Å£»ÇËá¿ÉÒÔÑÓÉìÒ°Éú´ÆÐÔСÊó¿µ½¡ÊÙÃü
Óë¼òÆÓÉúÑÄʱ³¤µÄÑÓÐøÏà±È£¬ÓÐÒâÒåµÄ¿¹ÐàÂõÁÆ·¨Ó¦¸Ã¸ÄÉÆ¿µ½¡µÄÉúÑÄʱÆÚ¡£ÎªÁËÆÀ¹ÀÅ£»ÇËáÔö²¹¼Á¶Ô¿µ½¡ÉúÑÄʱÆÚµÄÓ°Ï죬Ñо¿Ö°Ô±¶Ô14ÔÂÁäµÄСÊó¾ÙÐÐÒ»Á¬10-12¸öÔÂÅ£»ÇËáÔö²¹¼ÁËÇ飬Ëæºóͨ¹ý¹¦Ð§²â¶¨¼°×éÖ¯ÆÊÎöÀ´ÆÊÎö¹Ç÷À£¬¼¡È⣬´óÄÔ£¬ÒÈÏÙ£¬Ö¬·¾£¬³¦µÀºÍÃâÒßϵͳµÄ¿µ½¡×´Ì¬¡£Óë±ÈÕÕ×éÏà±È£¬Å£»ÇËáÔö²¹×éСÊóÌåÖØÔöÌí½µµÍ£¨Í¼2. A, B£©¡¢¹ÇÁ¿ÔöÌí£¨Í¼2. C£©¡¢¼¡ÈâʵÁ¦ÔöÌí£¨Í¼2. E, F£©£»ÐüβʵÑé¡¢Ã÷°µÏäʵÑéºÍYÐÎÃÔ¹¬ÊµÑéЧ¹ûÏÔʾ£¬Å£»ÇËáÔö²¹×éСÊóÒÖÓôÑùÐÐΪ½ÏÉÙ¡¢Ì½Ë÷ºÃÆæÐĸüÇ¿£¨Í¼2. G, H£©£»ÆÏÌÑÌÇÄÍÁ¿ÊµÑéºÍÒȵºËØÄÍÊÜÐÔʵÑéЧ¹ûÏÔʾ£¬Å£»ÇËáÔö²¹×éСÊó´úлÆÏÌÑÌÇÄÜÁ¦¼°ÒȵºËØÃô¸ÐÐÔ¶¼ÓÐÏÔןÄÉÆ£¨Í¼2. I£©£¬ÇÒ賦µÀתÔËËÙÂʸü¿ì£¨Í¼2. J£©¡£³ý´ËÖ®Í⣬Ôö²¹¸ß¼ÁÁ¿Å£»ÇËá¶ÔÐàÂõ¸öÌåÖзºÆðµÄÑ×֢״̬Ïà¹ØµÄËèϵ°×ϸ°ûÒì³£ÓиÄÉÆ×÷Óã¨Í¼2. K£©¡£»ùÓÚÒÔÉÏЧ¹ûÅú×¢ÖÐÄêСÊóÔö²¹Å£»ÇËá²»µ«¿ÉÒÔ¸ÄÉƶàÆ÷¹Ù¹¦Ð§£¬»¹ÄÜÑÓÉìÆ俵½¡ÊÙÃü¡£
ͼ2 Ôö²¹Å£»ÇËá¿ÉÔöÌíСÊóµÄ¿µ½¡ÊÙÃü
03 Å£»ÇËáÑÓÉ쿵½¡ÊÙÃüµÄ×÷ÓûúÖÆ
»ùÓÚÉÏÊö·¢Ã÷£¬Ñо¿Ö°Ô±½øÒ»²½¶ÔÅ£»ÇËáÓ°Ïìϸ°û¹¦Ð§ÒÔÑÓÉ쿵½¡ÊÙÃüµÄ»úÖƾÙÐÐÁË̽ÌÖ¡£Ê×ÏȶÔÒ°ÉúÐͺÍÅ£»ÇËáȱÏÝСÊóÖпÉÒÔ´ó×Ú±í´ïÅ£»ÇËáתÔËÂÑ°×£¨ÓÉSlc6a6±àÂ룩µÄ³É¹Çϸ°û¾ÙÐÐת¼×é²âÐò(RNA Sequencing, RNA-seq)¡£Å£»ÇËáȱÏÝСÊó³É¹Çϸ°ûRNA-seqÆÊÎöÏÔʾ£¬¶ËÁ£¹¦Ð§£¬Ñõ»¯Ó¦¼¤£¬ÃâÒß¹¦Ð§£¬ÂÑ°×ÖÊ·ÒëºÍ¸Éϸ°ûά³ÖµÈ;¾¶ÓëÒ°ÉúÐÍСÊó³É¹Çϸ°û±£´æÏÔ×Ųî±ð£¨Í¼3. A£©¡£³ý´ËÖ®Í⣬Ñо¿Ö°Ô±»¹¹¹½¨ÁËÏÈÌìÐÔÅ£»ÇËáȱ·¦Ð¡ÊóÄ£×Ó(Slc6a6?/?)̽ÌÖÐàÂõϸ°ûµÄ»ýÀÛÊÇ·ñÓÕµ¼Å£»ÇËáȱ·¦µÄСÊó¿µ½¡ÊÙÃüÊÜËð¡£ÓëÒ°ÉúÐÍСÊóÏà±È£¬Slc6a6?/?СÊóÊÙÃü½Ï¶Ì¡£¶ÔSlc6a6?/?СÊó¾ÙÐÐɨ³ýÐàÂõϸ°ûµÄsenolyticÖÎÁÆ£¬ÖÎÁƺóµÄСÊóÊÙÃüÖ»ÔöÌíÁËÔ¼21%£¬ÕâһЧ¹û˵Ã÷Å£»ÇËỹӰÏìÐàÂõÒÔÍâµÄÆäËûÒòËØ£¨Í¼3. B£©¡£
ΪÁ˽øÒ»²½·¢Ã÷Å£»ÇËáºÍÆäËûÐàÂõÌØÕ÷·Ö×Ó¼°Ï¸°ûÌØÕ÷Ö®¼äµÄ¹Øϵ¡£Ñо¿Ö°Ô±¹¹½¨Á˶ËÁ£Ã¸È±ÏݵİßÂíÓãÄ£×Ó(Tert-/-)À´Ì½ÌÖÅ£»ÇËáÊÇ·ñÓ°Ïì¶ËÁ£Ã¸È±·¦ÒýÆðµÄ»úÌ念½¡¶ñ»¯£¬Ð§¹ûÏÔʾԼĪ40%µÄÓãÔÚÊܾ«ºó10ÌìÄÚéæÃü£¬¶øÔö²¹Å£»ÇËáÄÜÏÔÖøÌá¸ß´æ»îÂÊ¡¢ÒÖÖÆÐàÂõÀú³Ì£¨Í¼3. C-E£©¡£Ëæºó£¬»ùÓÚСÊóÄ£×ÓµÄÑé֤ʵÑé·¢Ã÷Ôö²¹Å£»ÇËá¿ÉÒÔ½µµÍѪÇå8-ôÇ»ùÍÑÑõÄñÜÕ(8-hydroxydeoxyguanosine, 8-OH-dG)Ʒò£¬ÒÖÖÆDNAËðÉË£¨Í¼3. F£©£»¿ÉÒÔÌá¸ßDNAËðÉ˺óСÊóµÄ´æ»îÂÊ£¨Í¼3. G£©£»¿ÉÒÔÓ°Ïì¼×»ù»¯Ä£Ê½£¬¸Ä±äȾɫÖʹ¹Ï󣬽ø¶øÓ°ÏìÐàÂõÀú³ÌÖеÄת¼¸Ä±ä£¨Í¼3. H£©£»¿ÉÒÔ½µµÍ¸ÎÔà¡¢×ØÉ«Ö¬·¾µÈ×éÖ¯ÖÐRS6PµÄÁ×Ëữ£¬Î¬³ÖÂÑ°×ÎÈ̬£¨Í¼3. I£©£»¿ÉÒÔ½µµÍ´ÙÑ×Òò×Óˮƽ£¬±ÜÃâÐàÂõÀú³ÌÖб¬·¢µÄ´ÙÑ×״̬£¨Í¼3. J£©£»¿ÉÒÔÔöÌí³£×¤¸Éϸ°ûµÄÊýÄ¿£¬½ø¶øÌá¸ßijЩ×éÖ¯µÄÔÙÉúÄÜÁ¦£¨Í¼3. K£©£»¿ÉÒÔ½µµÍROSÓÕµ¼µÄÖ¬ÖʹýÑõ»¯ºÍÂÑ°×ôÊ»ù»¯£¬Ôö½øÏßÁ£ÌåÎÈ̬£¨Í¼3. L£©¡£
»ùÓÚÒÑÓеÄÑо¿±¨µÀ£¬°ûÖÊÅ£»ÇËᱻתÔ˵½ÏßÁ£Ìåºó£¬ÓëtRNALeuµÄÌض¨ÄòÜղлùÍŽáÐγÉtm5U-tRNA£¬tm5UÐÞÊζÔÏßÁ£ÌåtRNAs¾ßÓÐÆæÒìÐÔ£¬²¢ÇÒËüÄÜÔö½øµç×Óת´ïÁ´¸´ºÏÌåIÑÇ»ùND6µÄ·Òë¡£Ñо¿Ö°Ô±ÕÉÁ¿ÁËtm5U-tRNAÐÞÊÎÔÚСÊóÐàÂõÀú³ÌÖÐÊÇ·ñ±¬·¢×ª±ä£¬Ð§¹ûÏÔʾ£ºÓëÄêÇáСÊó¸ÎÔàÏà±È£¬ÍíÄêСÊó¸ÎÔàÖÐtRNAsµÄtm5Uº¬Á¿Ï½µÁè¼Ý60%ÒÔÉÏ£¬¶øÔö²¹Å£»ÇËáµÄСÊó½öϽµÁË20%×óÓÒ£¨Í¼3. M£©¡£ND6ÂÑ°×·ÒëˮƽҲÏÔʾ³öÏàͬµÄÇ÷ÊÆ£¬ËæºóµÄÈä³æʵÑéÒ²½øÒ»²½ÌáÐÑÅ£»ÇËá¿ÉÄÜͨ¹ýÔöÌíÏßÁ£Ì帴ºÏÌåIµÄ»îÐÔÀ´Ôö½ø¿µ½¡£¨Í¼3. N, O£©¡£
ͼ3 Å£»ÇËá¶Ô¿µ½¡ÊÙÃüµÄµ÷ÀíÓë¶àÖÖÐàÂõ±ê¼ÇµÄ¸Ä±äÓйØ
04 Å£»ÇËáÔÚÁ鳤ÀàÉúÎïÖеÄ×÷ÓÃDZÁ¦
ΪÁËÈ·¶¨Å£»ÇËá¼°Æä´úл²úÆ·£¨´ÎÅ£»ÇËáºÍN-ÒÒõ£»ùÅ£»ÇËᣩµÄѪҺˮƽÊÇ·ñÓëÈËÀàµÄ¿µ½¡±äÁ¿Ïà¹Ø£¬Ñо¿Ö°Ô±¶Ô11966ÃûÊÜÊÔÕßµÄÅ£»ÇËá¼°Æä´úлÎïˮƽÓë50¶à¸öÁÙ´²Î£º¦ÒòËؾÙÐÐÁ˹ØÁªÆÊÎö£¬Ð§¹ûÏÔʾѪҺÖÐÅ£»ÇËá¼°ÆäÏà¹Ø´úлÎïˮƽ½Ï¸ßµÄÊÜÊÔÕߣ¬ÆäÌåÖØÖ¸Êý(body mass index, BMI)½ÏµÍ¡¢·ÊÅÖˮƽ½ÏµÍ¡¢2ÐÍÌÇÄò²¡»¼²¡Âʽϵ͡¢Ñ×֢ˮƽ½ÏµÍ£¨Í¼4. A£©¡£Ëæºó£¬×÷Õßͨ¹ý¶ÔÔË·¢¶¯ºÍ¾Ã×øÈËȺµÄѪÇåÅ£»ÇËá´úлÎïŨ¶ÈµÄÆÊÎöÀ´Ì½ÌÖÅ£»ÇËáˮƽÊÇ·ñ»á¶ÔÔ˶¯±¬·¢ÏìÓ¦£¬¶øÔ˶¯ÊÇÒÑÖªµÄ¿É¸ÄÉÆ¿µ½¡µÄ¸ÉÔ¤²½·¥¡£Ð§¹ûÏÔʾ£ºÎÞÂÛÊÇÔË·¢¶¯×éÕվɾÃ×ø²»¶¯×飬Ô˶¯ºóÆäѪÇåÖÐÅ£»ÇËá¼°´ÎÅ£»ÇËáµÄŨ¶È¶¼·ºÆðÔöÌí£¨Í¼4. B-D£©£¬ÕâЩЧ¹ûÅúעţ»ÇËáºÍÅ£»ÇËáÏà¹Ø´úлÎïµÄÔöÌí¿ÉÄܽ鵼Ô˶¯´øÀ´µÄÏà¹ØÒæ´¦¡£×îºó£¬Ñо¿Ö°Ô±Í¨¹ýËÇιÍíÄêºãºÓºïÀ´Ì½ÌÖÅ£»ÇËáÔÚ·ÇÈËÁ鳤ÀදÎïÖÐÊÇ·ñ¾ßÓпµ½¡ºÍ¿¹ÐàÂõ×÷Óá£Í¨¹ýÒ»Á¬6¸öÔµÄÅ£»ÇËáÔö²¹£¬·¢Ã÷Óë±ÈÕÕ×éÏà±È£¬Ôö²¹Å£»ÇËá×éÖ¬·¾±ÈÀýϽµ£¬¹ÇÃܶÈÔöÌí£¬ÑªÌÇŨ¶ÈϽµ£¬¸ÎËðÉ˱ê¼ÇÎïŨ¶ÈϽµ£¬ËæÄêËêÔöÌíµÄ°×ϸ°û¡¢µ¥ºËϸ°ûºÍÁ£Ï¸°ûµÄÊýÄ¿·ºÆðϽµ£¬ROSÓÕµ¼·Ö×ÓËðÉ˵ļä½Ó±ê¼ÇÎï8-OH-dGŨ¶ÈϽµ£¬Ö¬ÖʹýÑõ»¯Îï¼°ÂÑ°×ÖÊôÊ»ùŨ¶ÈϽµ£¨Í¼4. E-O£©¡£
ͼ4 Å£»ÇËá;¾¶Ó°ÏìÁ鳤ÀදÎïµÄ¿µ½¡ÊÙÃü
×ܵÄÀ´Ëµ£¬ÒÔÉÏЧ¹ûÅúעţ»ÇËáŨ¶ÈËæ×ÅÐàÂõÀú³Ì¶ø½µµÍ£¬¶øÔö²¹Å£»ÇËá¿ÉÒÔÒÖÖÆÕâÖÖϽµ£¬ÔöÌí²î±ðÎïÖֵĿµ½¡ÊÙÃü£¬ÕâҲȷ¶¨ÁËÅ£»ÇËáȱ·¦ÊÇÕâЩÎïÖÖÐàÂõµÄÇý¶¯ÒòËØ£¬¶øÔö²¹Å£»ÇËá¿ÉÒÔ×÷ΪÑÓ»ºÐàÂõµÄÒ»ÖÖDZÔÚÖÎÁÆÕ½ÂÔ£¬ÈôÊÇÏëÒªÔÚÁÙ´²ÖÐÓ¦Óã¬ÈÔÐè½øÒ»²½¾ÙÐÐËæ»ú±ÈÕÕµÄÁÙ´²ÊÔÑ飬ÒÔÆÀ¹ÀÅ£»ÇËáµÄ¿¹ÐàÂõ×÷Óá£
½áÓï
×÷Ϊ×é³ÉÉúÃüÎïÖÊ»ù´¡ÂÑ°××éµÄ»ù±¾×é³Éµ¥Î»£¬°±»ùËáÔÚÉúÃüÌåµÄÉú³¤·¢ÓýÀú³ÌÖÐÆðµ½ÖÁ¹ØÖ÷ÒªµÄ×÷Óã¬ÖÖÖÖÀà°±»ùËáÓëÐàÂõÖ®¼äµÄ¹ØϵҲ±»Ñо¿Õß¹Ø×¢¡£³ýÁ˱¾Ñо¿Åú×¢µÄÅ£»ÇËáºÍÐàÂõÀú³ÌÓÐÏÔÖøµÄÁªÏµ£¬ÏÈÇ°ÓÐÑо¿±¨µÀÏÞÖÆÒûʳÖе°°±Ëá¼°Ö§Á´°±»ùËá(Branched chain amino acid, BCAA)£¬¿ÉÒÔ¸ÄÉÆÒȵºËضԿ¹¡¢Ñõ»¯Ó¦¼¤ÔöÌíµÈ¶àÖÖÐàÂõ±ê¼ÇÕ÷Ïó[6]¡£½ñÄê3Ô·ÝÏÃÃÅ´óѧÕŽܡ¢ÀäÀú¸èÍŶÓͨ¹ýÑо¿·¢Ã÷Ôö²¹D-Ë¿°±Ëᣬ¿ÉÒÔÔö½øÏÂÇðÄÔÖÐMeninÂѰ׵ıí´ï£¬ÓÐÖúÓÚÌá¸ß»úÌåµÄ´úлÎÈ̬£¬´Ó¶ø×è°ÐàÂõÀú³ÌµÄ¼ÓËÙ[7]¡£Òò´ËÏàʶÖÖÖÖ°±»ùËáÔÚÉúÎïÌåÖеÄŨ¶Èת±ä¿ÉÒÔÓÐÓüà²âÉúÎïÌåµÄÐÄÀíºÍ²¡Àí״̬¡£
°¢È¤ÓÚ½ñÄê¶Ô°±»ùËá¾ÙÐÐÉý¼¶£¬Éý¼¶ºóµÄ°±»ùËápro¿ÉÒÔ¼ì²â³£¼ûµÄÖ§Á´°±»ùËá¡¢DÐÍ°±»ùËáÒÔ¼°Å£»ÇËáµÈ70ÓàÖÖ°±»ùËᣬʹÓÃͬλËØÄڱ귨¾ø¶Ô¶¨Á¿£¬¶¨Á¿×¼È·¶È¸ß£¬¼Ó±ê½ÓÄÉÂÊÔÚ80%-120%Ö®¼ä¡£Éý¼¶ºó°±»ùËápro¾ßÓж¨Á¿×¼¡¢ÁýÕֹ㡢ѸËٶȸߡ¢¿ÉÖظ´ÐÔµÈÌص㡣½Ó´ýÓа±»ùËá¾ø¶Ô¶¨Á¿ÐèÇóµÄÏÈÉúÁªÏµbeat365Õý°æΨһ¹ÙÍø£¡
²Î¿¼ÎÄÏ×£º
1. Gems D, Partridge L. Genetics of longevity in model organisms: debates and paradigm shifts. Annu Rev Physiol. 2013;75:621-44. doi: 10.1146/annurev-physiol-030212-183712;
2. Campisi J, et. al.. From discoveries in ageing research to therapeutics for healthy ageing. Nature. 2019 Jul;571(7764):183-192. doi: 10.1038/s41586-019-1365-2;
3. Mkrtchyan GV, et. al.. ARDD 2020: from aging mechanisms to interventions. Aging (Albany NY). 2020 Dec 30;12(24):24484-24503. doi: 10.18632/aging.202454;
4. Warskulat U, et. al.. Phenotype of the taurine transporter knockout mouse. Methods Enzymol. 2007;428:439-58. doi: 10.1016/S0076-6879(07)28025-5;
5.?Singh P, et. al.. Taurine deficiency as a driver of aging. Science. 2023 Jun 9;380(6649):eabn9257. doi: 10.1126/science.abn9257;
6. Green CL, Lamming DW, Fontana L. Molecular mechanisms of dietary restriction promoting health and longevity. Nat Rev Mol Cell Biol. 2022 Jan;23(1):56-73. doi: 10.1038/s41580-021-00411-4;
7. Leng L,et. al.. Hypothalamic Menin regulates systemic aging and cognitive decline. PLoS Biol. 2023 Mar 16;21(3):e3002033. doi: 10.1371/journal.pbio.3002033.
ÎÄÏ×ÏÂÔØÁ´½Ó£º
https://pan.www.virgo68.net/s/15QNrbffylTwSDmVsBWV3dw
ÌáÈ¡Â룺0000
